Extension without change of a currently approved collection
No
Regular
12/19/2023
Requested
Previously Approved
36 Months From Approved
02/29/2024
5,613
4,577
174,289
123,673
0
0
This information is required to
support implementation and administration of the Orphan Drug Act
and FDA regulations found in 21 CFR part 316. The information is
necessary to show that applicants qualify and continue to qualify
for the incentives and assistance provided by the applicable
statutes and regulations.
We have adjusted our burden
estimate to reflect an overall increase of 50,616 hours and 1,036
records annually. We attribute the adjustment to an increase in the
number of submissions, amendments, and annual reports, as well as a
comprehensive evaluation of the information collection.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.